Marimastat
N/A
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameMarimastat
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co IncMitsubishi Tanabe Pharma Corp
China Registration ClassN/A
Develop Information
Active CompaniesLiverpool School Of Tropical Medicine
Inactive CompaniesIlex Oncology Services IncNational Cancer Institute
Active Indications
Inactive Indications